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    Transcatheter artificial embolization was therapeutically carried out ．in 26 patients with renal
Cell carcinoma， in 3 with secondary inet’astatic renal tumor and in 2 with intractable bladder hetnor－
rhage． Effects of embglization were evaluated from the clinical points as follows： i） cessation of bloed
flow， ii）i皿provement of clinical symptoms， iii）embolization effects seen in the extirpated kidney and
its pathological findings， and iv） patient’s survival． Subjective evaluation of embo1ization was also
performed from both sides of patients and physicians．
   Although cessation of blood fiow can b’e observed on the arteriogram after ernbolization， 99mTc－
DMSA renal scintigraphy is an useful adjunct iCor detecting renal bloe．d fiow serially． Recannalization
of embolized arteries often occurred around 2 months after embolization． There are two rnodes in
recurrence． One is recannalization， the other is a neovascularity ．of the turpor in the area where eipbo－
lization did not extend in the previous treatment． Disappearance of hematuria was the most prGmi－
nent aspect in improvement 6f clinical symptoms．
   Embolization effects could be seen in．the exti；pated kidney and its histological findin．rrs． How－
ever， tumor necrosis was noticed only partly and intact tumor portions were always found in the histo－
logical examination． Embolization itself did not always exert good effect on the surgical procedure
or the patient’s survival． There was a good coillcidence of 600／． between subjective evaluation of
embolization in patients and that in physicians．．．
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  From these studies， we proposed indication for therapeutic embolization in urology． As the
first category， intractable hemorrhage from the kidney or bladder and inoperable renal cell carcinoma
or secondary renal tumor are included． As one of extended applications， medical nephrectomy by
embolization is indicated in a variety of renal diseases． Embolization as a preoperative treatment
for renal cell carcinoma should be taken into consideration on the balance between the severity of
hematuria and untoward effects after embolization．
























































  Unknown Etiology H一一”1
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Table 2． Criteria for the effects of embolization
CRrTERrA FOR EMBOLIZATION EFFECTS
Objective Evatuation
 Cessation of Renal Btood Ftow
Improvement of Ciinical Symptoms




     good， neither good nor bad， bad
Doctor’s Side





































Disappearance of Macroscopic Hematuria
Decreased Size of Rena（ Mass




Pain in the Gluteal Region
Contracted Btadder
Controt of Massive Bteeding
 Immediate Cessation
 No Further Episodes
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 b    ”T7 OV3  Days after Embolization
Increment （increased percent） of serum LDH and
alkaline phosphatase following emboljzation．
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。   O   l 3 7        Days after Embo［iration
Fig． 3． Change of white blood cell cbunt in peripheral
    blood following embolization．
Table 4．Schematic presentation of cessation in renal
blood flow following embolization
Cessation of Renat Blood FS．o－t
Rena［ Arteriogramafter Ernbotization
mmediatetyLevel Number of Cases
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Before
Fig． 4．
                     After
       Embolization
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Late image
Bofore embolization
            After embolization
Fig． 6． 99mTc－DMSA renal scintigrams before （upper） and after （lower）
    ernbolization． An open arrow indicates a hot area with DMSA
    uptake in the early image， while a closed arrow a cold area
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Before embolization
18 Months after embolization
    Early image Late irnage


















Fig． 9． Upper： Right renal arteriograms before and after the initial
    embolization． Lower： Right renal arteriogram 3 months after
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Fig． 10－a．Cut surface of the left kidney． A well demarcated tumor
occupies lower lateral portion of the kidney．





































Microscopic finding shows a hemorrhagic infarct from the
embolized kidney 3 days after embolization．
Fig． 12－a． Microscopic finding from the kidney 11 months after embolization
     shows a disordered arrangement of tumor cells with vacuolated
     degeneration and interstitial fibrosis． Partly， tumor cells with large
     nuclei are seen．
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難算鯉瓢    薫撃獅
螺講難幽
Tumor cells consisting of clear cel！ type are scattered among
hemorrhage and fibrosis induced by embolization．
Fig． 12－b．Newly d veloped tumor cells are seen with a degenerated
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  Table 5． Improvement of clinical symptoms Table 6． Effects of embolization on the surgery
IMPROVEMENT OF CLINICAL SYMPTOMS
Disappearance of hematuria
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EFFECT OF EMBOLIZATION ON THE SURGERY ［n＝20J
Eosy operability一一一一一一一一一一一一一一一一
Decreosed bleeding volbme during the surgery一一一一一一一一
No effects
       No evaluation
Decrea ed size of renal
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       6 12 18 24 30 ．36                       Months
13． Relative survival rate in 29 patients with renal ce！1 carcinoma．
 Table 7． Subjective evaluationr．of embolizationJiinJ’patients
           and physicians
RenatTumor
Patient’s Evatuation
       good
  neither gopd nor bad
       bad
Doctor’s Evatuation
      effective
     indifterent
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Ai Others
Patient’s Evaluati6n’
Fig． 14．Correlation study between subjective evaluation of
embolization in patients and that in physicians．
Table 8． lndication to therapeutic embolization in UrolQgy
iNDICATION TO THERAPEUTIC EMBOLiZATION I N UROLOGY
1． lntrdctable renol hemorrhage
      Arteriovenous fistulo （congenitoi or acquired ）
      Seconaary renal tumor
      Inoperoble rend cell carcinoma ＆ rena［ pelvic tumor
I． lntroctable blodder or prostatic hemorrhoge
M． Preoperotive treatrnent
      Oncologic alteretions by cessation of the blood f low
      Eesy operobility ＆ reduction of blood ］oss during the operotion
      Shrinkege of the renai mass
工▽l ApPlicotion to other reno【diseases
      Malignant hypertension
      Polycystic kid．ney disease
      Erid stage renol diseose
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